Active Ingredient(s): Trilaciclib Dihydrochloride
FDA Approved: * February 12, 2021
Pharm Company: * G1 THERAP
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cosela Overview

Trilaciclib, sold under the brand name Cosela, is a medication used to reduce the frequency of chemotherapy-induced bone marrow suppression.[1][2][3] The most common side effects include fatigue; low levels of calcium, potassium and phosphate; increased levels of an enzyme called aspartate aminotransferase; headache; and infection in the lungs (pneumonia).[2] Trilaciclib may help protect bone marrow cells from damage caused by ch...

Read more Cosela Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Cosela Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trilaciclib Dihydrochloride
  • Powder: 300mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Trilaciclib Dihydrochloride or a similar ingredient: (1 result)